Schizophrenia News

TORONTO — The 168th annual meeting of the American Psychiatric Association will feature innovative clinical research and practice-related sessions on topics including suicide risk factors in the ED, exposure to terrorism and substance abuse among college students.

Among immigrants residing in Ontario, refugee status was a significant predictor of schizophrenia or schizoaffective disorders and immigrants from the Caribbean and Bermuda had the highest incidence rates, according to study results.

Researchers from the University of Virginia School of Medicine and University of Michigan have received a 5-year grant from the National Institute of Mental Health to investigate genetic causes of schizophrenia.

The FDA today approved generic versions of Abilify for treatment of schizophrenia and bipolar disorder.

Psychosis progression among patients at ultra-high clinical risk is greatest during the first months after clinical presentation, according to study findings in JAMA Psychiatry.

Results from a randomized, multicenter study indicate that once monthly Invega Sustenna was superior to oral antipsychotics in delaying treatment failure among adults with schizophrenia.

Results from a multicenter, randomized, double-blind, placebo-controlled study indicate that daily 2 or 4 mg doses of brexpiprazole were safe and effective among adults with acute schizophrenia.

At a national advisory council meeting Wednesday, members of the Substance Abuse and Mental Health Services Administration discussed potential approaches to mental health services that would achieve better patient outcomes while efficiently using available resources and recently awarded federal funding.

Overweight and obese patients with severe mental illnesses who met with a weekly health promotion coach in a public fitness club had clinically significant reductions in cardiovascular risk when compared to a similar group of patients with a fitness club membership alone, according to recent research.

Recent data suggest that elderly patients with dementia being treated with antipsychotics may have a greater increased risk for mortality than previously expected, according to researchers.